Arsenal Bridge Venture — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
COURAGE THERAPEUTICS, INC.May 2025SEC filingmedium confidence
BiotechNewton, US
Roger Cone(Director)Daniel Housman(Executive Officer, Director)
BoardBruce Leutcher(Director)
Board seatIsaac Barchas· per SEC Form D · $10.5M raise · filed May 2025
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.